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Background: The International Society for Pediatric and Adolescent Diabetes (ISPAD) and the American Diabetes
Association (ADA) have established a hemoglobin A1c (A1c) target of less than 7.5% for adolescents with type 1
diabetes (T1D). However, many adolescents are unaware of their A1c target, and little data exist on how knowledge
of this A1c target affects the actual A1c they achieve. We sought to evaluate the relationship between awareness of
the A1c target and the actual A1c achieved in adolescents with T1D.
Methods: In a cohort of 240 adolescents with T1D age 13–19 years, we measured A1c and administered a
questionnaire to assess their knowledge of the ISPAD guideline for A1c target.
Results: Of the total cohort, 42 subjects (18%) had an A1c below target and 198 subjects (82%) had an A1c above
target. Almost all subjects (98%) reported that they were told their A1c target by a healthcare provider, and most of
those (88%) claimed to know their A1c target, but few (8%) were correct. More subjects with actual A1c below 7.5%
thought their A1c goal was lower than the ISPAD target, compared to subjects with A1c above target (75% vs. 59%,
p = 0.07), although this did not achieve statistical significance.
Conclusion: In this cohort of adolescents with T1D, there was a trend toward a lower achieved A1c in those with a
lower perceived A1c goal. Further studies should focus on identification of factors influencing an adolescent’s ability
to achieve a lower A1c.
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Hemoglobin A1c (A1c) is a widely used measure of gly-
cemic control for patients with type 1 diabetes (T1D).
Elevated A1c is associated with increased risk of deve-
loping microvascular and macrovascular complications,
whereas an A1c less than 7.5% is associated with in-
creased hypoglycemia [1-3]. Debate exists regarding the
optimal A1c target for adolescents with T1D. Seeking to
minimize long-term complications of diabetes, while also
minimizing hypoglycemia, the International Society for
Pediatric and Adolescent Diabetes (ISPAD) has estab-
lished an A1c target of less than 7.5% for all children
and adolescents with T1D [4]. However, scant data exist
on how well adolescents can identify their A1c target or* Correspondence: scott.clements@hsc.utah.edu
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reproduction in any medium, provided the orhow knowledge of this A1c target relates to the actual
A1c achieved by adolescents [5,6].
One determinant of achieving the A1c target in ado-
lescents may be awareness of this target. If adolescents
are aware of the A1c target, they may be more likely to
work toward achieving that goal. If they are able to
achieve a lower A1c, their risk of developing long-term
complications of diabetes decreases. The purpose of this
analysis was to determine the relationship between
awareness of the A1c target and achievement of that tar-
get in a cohort of adolescents with T1D. We hypothe-
sized that subjects who were aware of the A1c target
would be more likely to achieve a lower A1c compared
to those not aware of the target.ral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Participants
Data were obtained from a cohort of 240 subjects, age
13–19 years with T1D for a minimum of 5 years, from
April 2008 through June 2010 [7]. Each subject was
managed by a pediatric endocrinologist and the diabetes
team at the Barbara Davis Center for Childhood Dia-
betes. There were an additional 60 subjects in the cohort
age 12 years who were excluded from this analysis due
to potential confusion between American Diabetes Asso-
ciation (<8%) and ISPAD (<7.5%) A1c targets for this
age. Study participants with T1D were diagnosed by islet
cell antibody and/or by provider clinical diagnosis. The
study was approved by the Colorado Multiple Institution
Review Board, and informed consent and assent (for sub-
jects <18 years) were obtained from all subjects.
All subjects were followed in a pediatric diabetes sub-
specialty clinic by a team including pediatric endocrino-
logists, nurses, dieticians, and social workers. Subjects
were generally seen every 3 months, with an A1c ob-
tained at every visit. Diabetes providers in general review
the target A1c of less than 7.5% with patients and fam-
ilies at every visit. On rare occasions, a provider may
have suggested a higher A1c goal to avoid hypoglycemia
or as a step towards better glycemic control in an ado-
lescent in poor control, but these situations do not occur
frequently.
Study visit
All subjects fasted overnight (≥8 hours). Medical history
was obtained with standardized questionnaires, inclu-
ding method of insulin administration (injections versus
insulin pump). As part of a survey regarding cardiovas-
cular health, subjects were asked questions about aware-
ness of their A1c target. Blood pressure measurements
were obtained after subjects had been laying supine for
a minimum of 5 minutes. Height was measured to the
nearest 0.1 cm with shoes removed using a wall-
mounted stadiometer, and weight was measured to the
nearest 0.1 kg using a Detecto scale. Tanner Stage was
assessed by a pediatric endocrinologist, except in 29
subjects who refused assessment of pubertal status by
a provider.
Laboratory assays
A1c was measured on the DCA Advantage by Siemens
(Princeton, New Jersey) at the Children’s Hospital Color-
ado main clinical lab. Total cholesterol, high-density
lipoprotein cholesterol (HDL-c), and triglycerides were
performed in the Clinical Translational Research Core
(CTRC) lab using an Olympus AU400e Chemistry
(Olympus, Brea, California). Low-density lipoprotein
cholesterol (LDL-c) was calculated using the Friedwald
formula.Categorization
The A1c target recommended by ISPAD of less than
7.5% for adolescents with T1D was used as the correct
target. Those subjects who stated they knew their A1c
target were asked to identify that target. Subjects were
initially divided into 3 categories based on their re-
sponses: stated A1c target was correct, stated A1c target
was below the ISPAD recommendation, and stated A1c
target was above the ISPAD recommendation. However,
some subjects stated an A1c range as the target, rather
than a discrete number. If their stated A1c range was
below the ISPAD recommendation of less than 7.5% (e.g.
6–7%), then they were included with the group whose
stated A1c target was below the ISPAD recommenda-
tion. If their stated A1c range was above the ISPAD re-
commendation of less than 7.5% (e.g. 8–10%), then they
were included with the group whose stated A1c target
was above the ISPAD recommendation. If their stated
A1c range included the ISPAD recommendation of less
than 7.5% (e.g. 7–8%), then their responses were consi-
dered as a fourth category and were analyzed separately.
Statistical analysis
Continuous variables were checked for the distributional
assumption of normality. Because the majority of vari-
ables exhibited a skewed distribution, Wilcoxon Sign
Rank test was used to test for differences between those
who achieved their A1c target and those who did not.
Chi-square test of independence or Fisher’s exact tests
were used to test differences among categorical variables.
Fisher’s exact test was used when there were fewer than
5 subjects in a group. Descriptive statistics are reported
as mean ± standard deviation or frequency and %. A
p-value of <0.05 was considered significant. SAS version
9.3 was used to perform statistical tests.
Results
Of the 240 adolescent subjects with T1D who were sur-
veyed, 52% were male, 78% were non-Hispanic white (11%
were Hispanic, 4.2% were black, 1.3% were American
Indian or Alaska Native, 0.8% were Hawaiian or Pacific
Islander, 0.4% were Asian, and 3.8% were mixed race),
mean age was 16.1 ± 1.8 years, diabetes duration was 9.0 ±
3.1 years (range 5.0–17.8 years), and mean A1c was 9.0% ±
1.7% (range 5.7%–14%). Clinical characteristics stratified by
A1c below or above target are shown in Table 1. A graph of
the actual A1c values by target A1c category is shown in
Figure 1. There were 42 subjects (18%) with A1c below tar-
get and 198 subjects (82%) with A1c above target.
Almost all subjects (98%, n = 237) reported that they had
been told their A1c target by a healthcare provider. Most of
those (88%, n = 212) claimed to know their A1c target. Of
the 212, only a small portion (8%, n = 18) were correct, 11%
stated a target above the recommended target, and 70%
Table 1 Characteristics of subjects with A1c below target compared to those with A1c above target
A1c below target A1c above target P-value
(N = 42) (N = 198)
Age (years) 15.9 ± 1.8 16.1 ± 1.8 0.33
Hemoglobin A1c,% 7.0 ± 0.5 9.5 ± 1.5 < 0.0001
Sex, n (% male) 24 (57.1%) 101 (51.0%) 0.70
BMI z-score 0.56 ± 0.71 0.70 ± 0.84 0.62
Ethnicity: 0.03
Non-Hispanic White 39 (92.9%) 149 (75.3%)
Hispanic 3 (7.1%) 36 (18.2%)
Other 0 (0%) 13 (6.6%)
Insulin pump use 28 (67%) 109 (55%) 0.16
Categorization:
Stated Target Correct 0 (0%) 18 (9.1%) 0.05*
Stated Target Incorrect 42 (100%) 180 (90.9%)
Stated Target Above vs. Other 3 (7.1%) 20 (10.1%) 0.24*
Stated Target Below vs. Other 31 (73.8%) 117 (59.1%) 0.07
Stated Target Included vs. Other 4 (9.5%) 19 (9.6%) 0.99*
No Stated Target Given vs. Other 4 (9.5%) 24 (12.1%) 0.79*
Systolic BP (mm Hg) 114 ± 9 115 ± 9 0.56
Diastolic BP (mm Hg) 67 ± 6 70 ± 7 0.02
Total Cholesterol (mg/dl) 144 ± 25 160 ± 38 0.007
LDL-c (mg/dl) 81 ± 21 91 ± 29 0.04
HDL-c (mg/dl) 48 ± 8 51 ± 11 0.50
Triglycerides (mg/dl) 70 ± 28 90 ± 53 0.02
Tanner Stage Pubic Hair: 0.76
1–3 5 (11.9%) 20 (10.1%)
4–5 31 (73.8%) 155 (78.3%)
Not assessed by provider 6 (14.3%) 23 (11.6%)
*Fisher’s Exact.
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42 subjects that stated the A1c target as a range, of which
18 (43%) gave a range that was completely below the cor-
rect A1c target (e.g. 6–7%) and are included in the below
target group, 1 (2%) gave a range that was completely above
the correct A1c target (e.g. 8–10%) and is included in the
above target group, and 23 (55%) gave a range that included
the correct A1c target (e.g. 7–8%) and were analyzed
separately.
Mean measured A1c in the 42 subjects below the
ISPAD target (<7.5%) was significantly lower compared
to the 198 subjects with A1c above target (7.0% vs. 9.5%,
p < 0.0001). Among subjects with A1c below 7.5%, 74%
thought their A1c target was lower than the actual tar-
get, compared to 59% of subjects above target (p = 0.07).
Interestingly, among subjects with A1c below 7.5%, none
stated the correct A1c target, whereas 18 subjects (9%)
with an A1c above 7.5% knew the correct A1c target.Age at diabetes diagnosis had no effect on perceived A1c
target (p = 0.23).
Those subjects with an insulin pump (n = 137) had an
average A1c of 8.6% ± 1.3%, whereas those using insulin
by injection (n = 103) had an average A1c of 9.7% ± 1.9%
(p = <0.0001). Of the 137 subjects using an insulin
pump, 28 had an A1c below 7.5%, compared to 14 of the
103 using insulin by injection (20% vs. 14%, p = 0.16).
Subjects who achieved A1c levels below 7.5% had lower
total cholesterol, LDL-c, triglycerides, and diastolic
blood pressure (p < 0.05 for all). There was no difference
in distribution by Tanner stage among those with A1c
below target versus those with A1c above target (Table 1,
p = 0.76).
Discussion
In this cohort of adolescents with T1D, the mean A1c of
9.0% was significantly higher than the ISPAD goal of less













Figure 1 Actual A1c by Target A1c Category. Actual A1c values
are shown by perceived A1c goal class. ● - subjects whose
perceived A1c goal was above the actual target. ■ - subjects whose
perceived A1c goal was below the actual target. ▲ - subjects whose
perceived A1c goal was correct. ▼ - subjects whose perceived A1c
goal was a range that included the actual target.
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in the T1D Exchange adolescent cohort (mean A1c
8.8%) and slightly higher than a cohort of adolescents
with T1D in the SEARCH for Diabetes in Youth study
(mean A1c 8.3%) [8,9]. We also found lower cardiovas-
cular disease risk factors (total cholesterol, LDL-c, tri-
glycerides, and diastolic blood pressure) in those
subjects with A1c below target compared to those with
A1c above target, which is also consistent with the
SEARCH adolescent cohort [10,11].
In this cohort, nearly all subjects claimed to know
their A1c target, but few were able to accurately identify
the A1c target of less than 7.5%. These data suggest that
few adolescents with T1D for 5 years or more are aware
of their A1c target, despite having diabetes for a mean of
almost 10 years. Furthermore, the adolescents in this co-
hort are all cared for at a large diabetes specialty center
by a team including a pediatric endocrinologist and dia-
betes educators, where diabetes education and A1c goals
are reviewed frequently. One would expect these sub-
jects to have a better understanding of diabetes than
other adolescents not seen at a diabetes specialty clinic.
There was a large number of pateints on insulin pumps,
suggesting a higher level of sophisticated diabetes care.
However, subjects on insulin pumps gave similar incor-
rect answers as those adolescents treated with insulin
injections.
Among those who believed their A1c goal was lower
than the actual A1c target, more subjects had A1c below
target than above target. The general trend suggests that
those who perceived their A1c goal to be lower than the
actual target were more likely to achieve an A1c below
the actual target, although this difference did not reachstatistical significance. While causality cannot be con-
firmed from our data, it would follow logically that ado-
lescents who perceive their A1c goal to be lower than
the actual target are more likely to strive to achieve that
lower goal.
Thus, lowering the A1c target for adolescents could
potentially lead to improved A1c levels and decreased
long-term complications of diabetes. However, lowering
the A1c target could also lead to an increased frequency
of hypoglycemia. Data from the Diabetes Control and
Complications Trial (DCCT) suggested that more inten-
sive therapy led to significantly higher rates of severe
hypoglycemia [3]. Although the DCCT was carried out
before the availability of current insulin analogs, the risk
for more frequent hypoglycemia should be considered
when determining A1c targets for this age group. It is
also possible that lowering the A1c target could lead to
greater disappointment at not achieving that goal, which
could result in unanticipated anxiety and frustration in
adolescents with type 1 diabetes. However, evidence re-
garding adolescent reactions to A1c goals is lacking.
ISPAD has set an A1c target of less than 7.5% for chil-
dren and adolescents with T1D [4]. This recommendation
is based on adolescent and adult data from the DCCT,
which showed that an elevated A1c was associated with in-
creased risk for development of microvascular and macro-
vascular complications and that a lower A1c was associated
with increased hypoglycemia [1-3]. The ISPAD A1c target
of less than 7.5% represents a balance between decreasing
long-term complications of diabetes and minimizing acute
episodes of hypoglycemia.
An adult study has shown that when patients know
their A1c, they are more likely to report better diabetes
care [12]. Similarly, a study in adolescents showed that
setting glycemic goals has a strong influence on A1c
outcomes [6]. However, another study in children and
adolescents has shown that there is a significant lack of
knowledge concerning the A1c test and the long-term
complications of an elevated A1c [5]. Our data are con-
sistent with these studies in that few adolescents (8%)
correctly identified their A1c target.
One of the main limitations of our study is that 42
subjects stated their A1c target as a range, rather than
identifying a discrete value. Of those, 23 subjects stated
an A1c target range that included the true A1c target of
less than 7.5%, many of whom stated their A1c target as
7–8%. If they had been required to give a discrete value
as an A1c target, it is unclear if they would have stated
less than 7%, 7.5%, or 8%. Thus, their responses required
separate analysis, rather than contributing to the analysis
of the entire cohort. Another limitation of our study is
that we do not have subject-specific data on what educa-
tion subjects received at each clinic visit. It is possible
that some providers may have suggested a higher A1c
Clements et al. International Journal of Pediatric Endocrinology 2013, 2013:17 Page 5 of 6
http://www.ijpeonline.com/content/2013/1/17goal for certain adolescents to avoid hypoglycemia or as
a step towards better glycemic control for those in poor
control. While we do not have recorded data on how
many study participants were given interim targets to
pursue improved glycemic control, we do know that all
patients were seen at a specialized diabetes clinic where
the recommended goals are generally considered to be
standard of care and are included in teaching materials
provided to all families [13]. An additional limitation of
our study is that some subjects may have been seen for a
study visit shortly after turning age 13 years, but had not
yet been seen at the diabetes clinic to discuss their A1c
target.
The prevalence of T1D is increasing in the U.S., and
adolescents make up a significant portion of those with
T1D [14,15]. Adolescence is a time of cognitive develop-
ment and increasing autonomy. As adolescents become
more independent and more mature, they begin to take
more responsibility for the management of their dia-
betes. This transfer of responsibility often occurs in the
early teenage years, and there are a number of factors
that can influence their ability to manage their diabetes.
One important factor that may influence how well ado-
lescents manage their diabetes is an awareness of treat-
ment goals. Our data suggest that adolescents who think
their A1c goal is lower than the ISPAD target may be
more likely to achieve a lower A1c.
Conclusions
In this cohort of adolescents with T1D, we found a gen-
eral trend that a lower perceived A1c goal was associated
with a lower achieved A1c. As adolescents become more
responsible for their diabetes care, a discussion of treat-
ment goals should be a consideration. It is important for
them to know their A1c target and understand how their
actual A1c compares to that target. Further studies
should focus on identification of other factors influen-
cing an adolescent’s ability to achieve a lower A1c with-
out excessive hypoglycemia.
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